{"id":"W4293507321","doi":"10.1111/hiv.13376","title":"Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic <scp>NRTI</scp> resistance","year":2022,"lang":"en","type":"article","venue":"HIV Medicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Tenofovir alafenamide; Emtricitabine; Medicine; Viral load; Virology; Dolutegravir; Resistance mutation; Internal medicine; Human immunodeficiency virus (HIV); Antiretroviral therapy; Reverse transcriptase; Biology; Polymerase chain reaction; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004006982,0.0003730645,0.0006882816,0.00061691,0.0002274692,0.000007997315,0.0002030031,0.0000622086,0.0004522549],"category_scores_gemma":[0.0002355877,0.0002623714,0.00005956143,0.001369026,0.0001465409,0.00008500698,0.0001081789,0.00047731,0.0001092581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000709706,"about_ca_system_score_gemma":0.0003667228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003028727,"about_ca_topic_score_gemma":0.00007669457,"domain_scores_codex":[0.9969181,0.000112859,0.0005748725,0.0005814309,0.001186875,0.0006258546],"domain_scores_gemma":[0.9986731,0.0002075026,0.0001833636,0.0005248757,0.0001319173,0.000279175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006331111,0.001034054,0.9094362,0.0001109417,0.0002074007,0.0008171742,0.004837683,0.00002184905,0.0001246356,0.0003951433,0.08103225,0.001349522],"study_design_scores_gemma":[0.01709926,0.0007519031,0.7910922,0.0002777277,0.0002307958,0.00002079489,0.001309606,0.00002951046,0.00007973512,0.0001758146,0.1887831,0.0001496069],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9675807,0.001557482,0.00008083817,0.008697726,0.0002439968,0.001273188,0.00003787881,0.0001437303,0.02038446],"genre_scores_gemma":[0.8640023,0.0000528771,0.001230928,0.001027982,0.00014568,0.0002649723,0.0008084949,0.00007528016,0.1323915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1183441,"threshold_uncertainty_score":0.9999828,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005847662508757921,"score_gpt":0.2025820058327435,"score_spread":0.1967343433239856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}